Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials

CONCLUSIONS: IV iron therapy holds promise for diminishing HF hospitalizations and enhancing quality of life and 6-minute walk test in HF patients. Yet, its effect on all-cause or cardiovascular mortalities appears limited.PMID:38628339 | PMC:PMC11018061 | DOI:10.1080/08998280.2024.2326387
Source: Baylor University Medical Center Proceedings - Category: Universities & Medical Training Authors: Source Type: research